Search

Your search keyword '"Montero C"' showing total 327 results
Start Over Author "Montero C" Database Unpaywall
327 results on '"Montero C"'

1. Effect of body mass index (BMI) on efficacy of immune checkpoint inhibitors (ICIs) in patients with metastatic urothelial carcinoma (mUC) in real-world setting.

Author

Lynn, David, primary, Dawsey, Scott, additional, Hobeika, Charbel, additional, Patgunarajah, Ubenthira, additional, Pramod, Nikhil, additional, Wei, Wei, additional, Nair, Monica, additional, Maroli, Kimberly, additional, Martin, Allison, additional, Ornstein, Moshe Chaim, additional, Wee, Christopher Eing, additional, Gilligan, Timothy D., additional, Nizam, Amanda, additional, Bonham, Amanda, additional, Mian, Omar Y., additional, Pavicic, Paul G., additional, Diaz-Montero, C. Marcela, additional, and Gupta, Shilpa, additional

Published
2024
Full Text
View/download PDF

22. Supplementary Table S1 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

23. Supplementary Figure S5 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

24. Data from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

25. Supplementary Figure S4 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

26. Supplementary Figure S1 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

27. Data from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

28. Supplementary Table S3 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

29. Supplementary Figure S2 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

30. Supplementary Figure S3 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

31. Supplementary Figure S3 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

32. Supplementary Table S2 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

33. Supplementary Table S2 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

34. Supplementary Figure S5 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

35. Supplementary Table S1 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

36. Supplementary Figure S4 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

37. Supplementary Figure S1 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

38. Supplementary Figure S2 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

39. Supplementary Table S3 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, primary, Stabellini, Nickolas, primary, Mitchell, Carley, primary, Pavicic, Paul G., primary, Fu, Pingfu, primary, Rupani, Amit, primary, Husic, Hana, primary, Rayman, Patricia A., primary, Swaidani, Shadi, primary, Abraham, Jame, primary, Budd, G. Thomas, primary, Moore, Halle, primary, Al-Hilli, Zahraa, primary, Ko, Jennifer S., primary, Baar, Joseph, primary, Chan, Timothy A., primary, Alban, Tyler, primary, Diaz-Montero, C. Marcela, primary, and Montero, Alberto J., primary

Published
2024
Full Text
View/download PDF

41. Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Author

Wilkerson, Avia D., primary, Parthasarathy, Prerana Bangalore, additional, Stabellini, Nickolas, additional, Mitchell, Carley, additional, Pavicic, Paul G., additional, Fu, Pingfu, additional, Rupani, Amit, additional, Husic, Hana, additional, Rayman, Patricia A., additional, Swaidani, Shadi, additional, Abraham, Jame, additional, Budd, G. Thomas, additional, Moore, Halle, additional, Al-Hilli, Zahraa, additional, Ko, Jennifer S., additional, Baar, Joseph, additional, Chan, Timothy A., additional, Alban, Tyler, additional, Diaz-Montero, C. Marcela, additional, and Montero, Alberto J., additional

Published
2023
Full Text
View/download PDF

42. Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression

Author

Pavicic, Paul G., primary, Rayman, Patricia A., additional, Swaidani, Shadi, additional, Rupani, Amit, additional, Makarov, Vladimir, additional, Tannenbaum, Charles S., additional, Edwards, Robert P., additional, Vlad, Anda M., additional, Diaz-Montero, C. Marcela, additional, and Mahdi, Haider, additional

Published
2023
Full Text
View/download PDF

43. Abstract 2278: Dissecting immuno-genomic pathways of response and resistance to immunotherapy in metastatic urothelial carcinoma in a real-world cohort

Author

Pramod, Nikhil, primary, Pavicic, Paul, additional, Dawsey, Scott, additional, Shen, Alan, additional, Lodha, Roshan, additional, Ornstein, Moshe, additional, Mian, Omar, additional, Gilligan, Timothy, additional, Wee, Christopher, additional, Nizam, Amanda, additional, Nguyen, Jane, additional, Diaz-Montero, C. Marcela, additional, and Gupta, Shilpa, additional

Published
2023
Full Text
View/download PDF

44. Data from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs

Author

Tannenbaum, Charles S., primary, Rayman, Patricia A., primary, Pavicic, Paul G., primary, Kim, Jin Sub, primary, Wei, Wei, primary, Polefko, Alexandra, primary, Wallace, Wesley, primary, Rini, Brian I., primary, Morris-Stiff, Gareth, primary, Allende, Daniela S., primary, Hamilton, Thomas, primary, Finke, James H., primary, and Diaz-Montero, C. Marcela, primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure 1 from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs

Author

Tannenbaum, Charles S., primary, Rayman, Patricia A., primary, Pavicic, Paul G., primary, Kim, Jin Sub, primary, Wei, Wei, primary, Polefko, Alexandra, primary, Wallace, Wesley, primary, Rini, Brian I., primary, Morris-Stiff, Gareth, primary, Allende, Daniela S., primary, Hamilton, Thomas, primary, Finke, James H., primary, and Diaz-Montero, C. Marcela, primary

Published
2023
Full Text
View/download PDF

46. Supplementary Table from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs

Author

Tannenbaum, Charles S., primary, Rayman, Patricia A., primary, Pavicic, Paul G., primary, Kim, Jin Sub, primary, Wei, Wei, primary, Polefko, Alexandra, primary, Wallace, Wesley, primary, Rini, Brian I., primary, Morris-Stiff, Gareth, primary, Allende, Daniela S., primary, Hamilton, Thomas, primary, Finke, James H., primary, and Diaz-Montero, C. Marcela, primary

Published
2023
Full Text
View/download PDF

47. Supplementary Figures 2-4 from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs

Author

Tannenbaum, Charles S., primary, Rayman, Patricia A., primary, Pavicic, Paul G., primary, Kim, Jin Sub, primary, Wei, Wei, primary, Polefko, Alexandra, primary, Wallace, Wesley, primary, Rini, Brian I., primary, Morris-Stiff, Gareth, primary, Allende, Daniela S., primary, Hamilton, Thomas, primary, Finke, James H., primary, and Diaz-Montero, C. Marcela, primary

Published
2023
Full Text
View/download PDF

48. Supplementary Figures 2-4 from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs

Author

Tannenbaum, Charles S., primary, Rayman, Patricia A., primary, Pavicic, Paul G., primary, Kim, Jin Sub, primary, Wei, Wei, primary, Polefko, Alexandra, primary, Wallace, Wesley, primary, Rini, Brian I., primary, Morris-Stiff, Gareth, primary, Allende, Daniela S., primary, Hamilton, Thomas, primary, Finke, James H., primary, and Diaz-Montero, C. Marcela, primary

Published
2023
Full Text
View/download PDF

49. Abstract 1818: Developing an autologous humanized mouse model to assess responses to novel immunotherapeutics

Author

Phoon, Yee Peng, primary, Lopes, Jared E., additional, Pfannenstiel, Lukas W., additional, Diaz-Montero, C. Marcela, additional, Tian, Ye F., additional, Ernstoff, Marc S., additional, Funchain, Pauline, additional, Li, XiaoXia, additional, Losey, Heather C., additional, Winquist, Raymond J., additional, and Gastman, Brian R., additional

Published
2023
Full Text
View/download PDF

50. Supplementary Table from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs

Author

Tannenbaum, Charles S., primary, Rayman, Patricia A., primary, Pavicic, Paul G., primary, Kim, Jin Sub, primary, Wei, Wei, primary, Polefko, Alexandra, primary, Wallace, Wesley, primary, Rini, Brian I., primary, Morris-Stiff, Gareth, primary, Allende, Daniela S., primary, Hamilton, Thomas, primary, Finke, James H., primary, and Diaz-Montero, C. Marcela, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results